Home » BD Biosciences names research grant recipients
BD Biosciences names research grant recipients
July 13, 2011
Biosciences, a segment of BD (Becton, Dickinson and Company), has announced the spring 2011 winners of its Research Grant Program.
An independent panel of scientists selected the winners. Each recipient will receive a $10,000 grant of research reagents to help them conduct their studies.
The winners of the BD Biosciences Research Grant Program for the spring 2011 cycle are:
- Richard Robinson, Ph.D., Assistant Professor, Medical College of Wisconsin, studies the effect of interleukin-12 receptor beta1 (IL12Rbeta1), a receptor generated by multiple immune cells that spans the cell membrane and binds to the p40-domain of IL 12 and IL 23, and IL 12p40 homodimer.
- Christopher Grigsby, a Ph.D. candidate at Duke University, is engineering polymeric nanocomplexes for oral delivery of therapeutic genes.
- Michael Sheard, Ph.D., Director, Flow Cytometry Core Facility, Children's Hospital Los Angeles, is studying natural killer cell-based immunotherapy for neuroblastoma.
- Flavia Pereira, Ph.D., post-doctoral fellow at the University of Connecticut Health Center, is studying the involvement of immune system cells involved in healing after a myocardial infarction.
- Doris Lambracht-Washington, Ph.D., Assistant Instructor, University of Texas Southwestern Medical Center, is developing a preclinical-stage vaccine for treating and preventing Alzheimer's disease (AD).
- Dean Lee, M.D., Ph.D., Assistant Professor, University of Texas MD Anderson Cancer Center, investigates adoptive natural killer (NK) cell immunotherapy for treating cancer.
- Yael Korin, Ph.D., Associated Researcher, UCLA Immunogenetics Center, will identify and validate immunological biomarkers in peripheral blood that may help predict tolerance in pediatric liver transplant recipients.
Upcoming Events
-
07May
-
14May